← Companies|Autolus Ther
AU

Autolus Ther

AUTL·NASDAQLondon UKFounded 2014300 employees
Small CapbiotechPublicOncologyHematology
Platform: Obe-cel CAR-T
Market Cap
$1.5B
All Drugs
2
Clinical Trials
5
Failed / Terminated
1
FDA Approved
1
Stock Price & Catalysts (AUTL)
Loading AUTL stock data...
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
NidarelsinAUT-2230Approved3Gene EditingFGFRCAR-T BCMAObesityADPKD
AUT-9774AUT-9774Phase 2/32Gene EditingBTKKRASG12DiHSMCC
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)
2025-01-25
Nidarelsin Ph3 Readout
ADPKD
Past
2026-07-21
Nidarelsin Ph3 Readout
Obesity
Ph3 Readout
2028-05-11
AUT-9774 Ph3 Readout
HS
Ph3 Readout
2030-12-27
AUT-9774 Ph3 Readout
MCC
Ph3 Readout